23.21
price up icon5.53%   1.2695
 
loading
前日終値:
$21.94
開ける:
$22.41
24時間の取引高:
16,333
Relative Volume:
0.08
時価総額:
$331.88M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+2.72%
1か月 パフォーマンス:
+34.46%
6か月 パフォーマンス:
+48.61%
1年 パフォーマンス:
-46.19%
1日の値動き範囲:
Value
$22.26
$23.88
1週間の範囲:
Value
$20.80
$23.88
52週間の値動き範囲:
Value
$6.875
$74.49

Neurogene Inc Stock (NGNE) Company Profile

Name
名前
Neurogene Inc
Name
セクター
Healthcare (1167)
Name
電話
(877) 237-5020
Name
住所
535 W 24TH STREET, NEW YORK
Name
職員
107
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
NGNE's Discussions on Twitter

NGNE を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NGNE
Neurogene Inc
23.27 306.21M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.41 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.58 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.94 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
569.93 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.32 29.19B 3.81B -644.79M -669.77M -6.24

Neurogene Inc Stock (NGNE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-17 開始されました Craig Hallum Buy
2025-05-16 ダウングレード Robert W. Baird Outperform → Neutral
2024-06-27 開始されました BMO Capital Markets Outperform
2024-06-11 開始されました Robert W. Baird Outperform
2024-04-29 開始されました Leerink Partners Outperform
2024-03-21 開始されました William Blair Outperform
2024-01-08 開始されました H.C. Wainwright Buy
2024-01-05 開始されました Stifel Buy
2024-01-04 開始されました TD Cowen Outperform
すべてを表示

Neurogene Inc (NGNE) 最新ニュース

pulisher
07:45 AM

What drives Neurogene Inc. stock priceMarket-crushing profits - Autocar Professional

07:45 AM
pulisher
07:43 AM

Is Neurogene Inc. a good long term investmentRobust investment performance - jammulinksnews.com

07:43 AM
pulisher
Jul 22, 2025

Neurogene Inc. Stock Analysis and ForecastSuperior portfolio returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Neurogene Inc. stock price move sharplyReal Time Stock Signal - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Neurogene Inc. stockFree Market Dynamics Reports - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

how neurogene inc. stock performs during market volatilityDefensive Stock Picks with Upside - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

How Neurogene Inc. stock performs during market volatilityHigh Return Conservative Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Neurogene Inc. stock attracts strong analyst attentionFree Investment Community - Newser

Jul 15, 2025
pulisher
Jul 05, 2025

Neurogene announces inducement grants - Medical Buyer

Jul 05, 2025
pulisher
Jul 03, 2025

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jul 03, 2025
pulisher
Jul 03, 2025

Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Jul 03, 2025
pulisher
Jul 01, 2025

Neurogene jumps as FDA approves rare gene therapy trial design - TradingView

Jul 01, 2025
pulisher
Jul 01, 2025

Stifel reiterates Buy rating on Neurogene stock, backs pivotal trial design - Investing.com

Jul 01, 2025
pulisher
Jun 30, 2025

FDA approves Neurogene’s Rett syndrome gene therapy registrational trial design - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Neurogene Announces Registrational Trial Design for Embolden™ Study of NGN-401 Gene Therapy for Rett Syndrome - Business Wire

Jun 30, 2025
pulisher
Jun 30, 2025

Neurogene Inc.(NasdaqGM: NGNE) dropped from Russell 3000E Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 18, 2025

Craig-Hallum bullish on Neurogene, initiates with a Buy - Yahoo Finance

Jun 18, 2025
pulisher
Jun 18, 2025

Neurogene (NASDAQ:NGNE) Coverage Initiated by Analysts at Craig Hallum - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

Neurogene (NGNE) Receives New Buy Rating from Craig-Hallum | NGN - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Neurogene (NGNE) Gains Attention with Promising Gene Therapy for - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Neurogene (NGNE) Receives Positive Coverage with a $50 Price Tar - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Neurogene (NGNE) Gains Attention with Promising Gene Therapy for Rett Syndrome | NGNE Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 14, 2025

Neurogene Reports First Quarter 2025 Financial Results and Highlights Recent Updates - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 13, 2025

BMO Capital Markets Issues Positive Forecast for Neurogene (NASDAQ:NGNE) Stock Price - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Neurogene’s (NGNE) Outperform Rating Reaffirmed at BMO Capital Markets - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Neurogene (NGNE) Price Target Raised by BMO Capital | NGNE Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Neurogene Approves Amendments at Annual Stockholders Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 11, 2025

Neurogene price target raised to $26 from $22 at BMO Capital - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

Neurogene Inc. (NASDAQ:NGNE) Receives $44.60 Consensus PT from Brokerages - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Two Sigma Investments LP Invests $472,000 in Neurogene Inc. (NASDAQ:NGNE) - Defense World

Jun 10, 2025

Neurogene Inc (NGNE) 財務データ

Neurogene Inc (NGNE) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$22.80
price up icon 4.56%
$36.00
price down icon 0.33%
$102.46
price down icon 0.38%
$27.78
price up icon 4.63%
$113.51
price up icon 1.86%
biotechnology ONC
$295.56
price up icon 0.00%
大文字化:     |  ボリューム (24 時間):